Erasca
Erasca, Corvus, and BioAge Target $500M+ Offerings Amid Biotech Fundraising Surge
Erasca; Corvus; BioAge; biotech offerings; fundraising; public offering
Biopharma Downsizing Trend 2024: Erasca, Bolt, Tenaya, and Other Industry Players Reduce Workforce
Biopharma, Layoffs, Downsizing, Erasca, Bolt, Tenaya, Industry Trends, Workforce Reduction, 2024
Erasca Pivots Strategy, Secures $160M and Licenses Chinese Cancer Drugs Amidst Workforce Restructuring
Erasca, pipeline, workforce reduction, licensing, cancer drugs, China, $160M, strategic shift